Pfizer and BioNTech Vaccine Sales Jump $1.4 Billion Thanks to AstraZeneca's Blunders

Keith Speights, The Motley Fool
·4-min read
Pfizer and BioNTech Vaccine Sales Jump $1.4 Billion Thanks to AstraZeneca's Blunders

The European Commission exercised its option to buy these doses under an existing agreement signed in February. This move brings the total doses the two companies are supplying to EU members to 600 million. From early on in the race to develop a COVID-19 vaccine, AstraZeneca seemed destined to be the top player in Europe.